In the randomized, sham-controlled ARTEMIS study, patients will receive either a dose of ixo-vec or a standard care regimen of anti-VEGF Eylea.
Several of these therapeutics use vectors derived from adeno-associated viruses (AAV) as a delivery mechanism to inhibit the expression of VEGF. However, they are in various stages of development.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results